University of Nevada School of Medicine,

Las Vegas, Nevada 89154

0 studies enrolling now · 27 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Arthritis, Rheumatoid, Breast Cancer, Candidiasis, Cardiovascular Risk, Chronic Kidney Disease, Crohn's Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyspnea

Studies at this site

• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed
• Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) — Completed
• Phase 3 Extension Study of Dexpramipexole in ALS — Stopped early
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• Phase 3 Study of Dexpramipexole in ALS — Completed
• Long-Term Safety Of PF-00547659 In Ulcerative Colitis — Completed
• Efficacy of Isradipine in Early Parkinson Disease — Completed
• A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) — Completed
• Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study — Completed
• ELND005 in Patients With Mild to Moderate Alzheimer's Disease — Completed
• Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight — Completed
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) — Completed
• Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Impact of Periodontal Disease on Outcomes in Diabetes — Completed
• Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12 — Status unconfirmed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed
• Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer — Stopped early
• ADNI: Alzheimer's Disease Neuroimaging Initiative — Completed
• Home-Based Assessment for Alzheimer Disease Prevention — Completed
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease — Completed
• An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED — Status unconfirmed
• EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
• Huperzine A in Alzheimer's Disease — Completed